Search

everythinglearnresearchcommunity

for

Search:↓

Acne patients' skin, both with and without lesions, shows a strong immune response and higher antimicrobial activity.

The review shows that skin symptoms like chronic fungal infections, hair loss, and skin depigmentation are key for early detection and management of APECED.

Booster shots of mRNA vaccines for COVID-19 increased protective antibodies without worsening autoimmune skin conditions in patients.

People with alopecia areata have fewer IL-10 producing immune cells, which might contribute to the condition.

Chronic graft-versus-host disease in the skin shows strong Th1 immune response and unique barrier issues.

Skin organoids with NCSTN mutation show changes in hair follicle development and higher inflammation, key features of Hidradenitis Suppurativa.

Tofacitinib regrew hair in a man with total hair loss but raised cytokine levels, needing more research on possible side effects.

In 2017, pediatric dermatology advanced with new treatments and insights into various skin conditions in children.

Cholecystokinin may help reduce skin inflammation in psoriasis.

Scalp psoriasis features reversible hair loss and specific immune activation, with no significant hair follicle damage.

Epiduo® is an effective first-line acne treatment that reduces inflammation and combats antibiotic resistance.

Higher levels of certain immune cells and proteins are linked to more severe lupus symptoms.

Small molecule DMF improves psoriasis and multiple sclerosis, adult skin cells can be made to grow new hair, certain skin cells initiate hair growth, IL-17C controls gut health and can cause skin inflammation, and skin cells produce IL-17 that can lead to psoriasis.

Vitamin B5 and coenzyme A may help regulate the immune system and could improve treatments for chronic diseases and cancer.

Ulcerative colitis can cause skin issues due to immune system problems.

STAT3 signaling is important for healthy skin and hair follicles, and its disruption can lead to skin conditions like atopic dermatitis.

A patient with Ivemark syndrome developed mixed type vitiligo after a hepatitis C infection, showing different treatment responses and immune cell involvement in the skin.

Tofacitinib may slow hair loss in scarring alopecias but is unlikely to regrow significant hair.

WNT10A mutations cause varied symptoms in patients with odonto-onycho-dermal dysplasia.

Tildrakizumab showed limited effectiveness in treating chronic alopecia areata in a small group of patients.

Photodynamic therapy may not work for erythroplasia of Queyrat and could lead to invasive squamous cell carcinoma.

Higher IL-17A levels indicate more severe alopecia areata.

Tofacitinib improved arthritis and partially improved hair loss in a lupus patient without side effects.

Acne is linked to inflammation and insulin resistance, and is associated with various syndromes that require different treatments.

Eating less sugar, milk, and saturated fats and more vegetables and fish may help treat and prevent acne.

Low vitamin D might be linked to certain types of hair loss, and supplements could help, but more research is needed.

Targeting CD200 could be a new treatment for rheumatoid arthritis.

Dupilumab for skin problems might reactivate hair loss in some patients.

A medication may help with hair growth in psoriasis, and a skin condition might be linked to a specific bacteria.

Chemical exposure may contribute to the rise in atopic diseases and needs more research.